drugset / Trial / NCT01398189

F-18 Altanserin PET Study of Patients Receiving Clozapine

NCT01398189

NaSingle-groupOpen-labelBasic science

Summary

To examine the feasibility of molecular imaging markers in clinical psychopharmacology

Timeline

Start
2011-07
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Background Clozapine Other / unclassified